SMi Systems
Andrew Thompson is the Founder & Director at SMi Systems, where Andrew has developed optical technology for molecular interactions. Prior to SMi, Andrew held positions at PetMedix, University of Cambridge, Acteon, Universität Bern, and NCorp LTD, with a background in research and software development. Andrew completed their PhD in Neurophysiology at the University of Nottingham.
This person is not in any teams
SMi Systems
SMi is an innovative life science technology company revolutionising molecular science with its ground-breaking single-molecule imaging platform. This transformational technology provides unprecedented AI-powered super-resolution imaging to directly observe and quantify molecules and their intricate interactions with unparalleled accuracy and reliability. SMi’s multi-omic platform offers highly scalable throughput and flexibility, allowing the detection of a broad range of molecule types within a single test. This unique approach facilitates faster, better informed decisions that will drive the future of therapeutic and diagnostic development. Established with a vision to bring its revolutionary platform to every laboratory bench, SMi delivers world-class results without the need for extensive training or specialized knowledge and will transform biomedical research and diagnostics through speed, quality and versatility.